KumhoHT

KumhoHT is a South Korean company that has strategically expanded from its core automotive lighting business into the life sciences and biotechnology sectors. Through its subsidiary KH Pharma and strategic acquisitions such as the Hungarian diagnostic firm Diatron and the biotech company S-Cube (Es-Cube), KumhoHT has established a presence in both the in-vitro diagnostics (IVD) and oncology drug development markets. The company's biotech portfolio focuses on developing next-generation anti-cancer therapies, including immune checkpoint inhibitors and targeted small molecules. KumhoHT leverages its manufacturing expertise and global network to commercialize diagnostic equipment and advance its clinical-stage therapeutic pipeline.